Climb Bio (CLYM) Operating Leases (2022 - 2026)
Climb Bio (CLYM) reported Operating Leases of $216000.0 for Q1 2026, down 32.29% on a YoY basis from $319000.0 in Q1 2025, and down 24.21% quarter-over-quarter from $285000.0 in Q4 2025.
Climb Bio (CLYM) Operating Leases (2022 - 2026) Analysis & Trends
Climb Bio has reported Operating Leases for 5 years, with the latest figure at $216000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 32.29% year-over-year to $216000.0; the trailing twelve-month figure through Mar 2026 stood at $216000.0 (down 32.29% YoY), and the FY2025 full-year result was $285000.0, down 24.0% from the prior year.
- Operating Leases for Q1 2026 stood at $216000.0, down from $285000.0 in the prior quarter.
- The five-year high for Operating Leases was $695000.0 in Q2 2022, with the low at $15000.0 in Q4 2023.
- Historically, Operating Leases has averaged $273928.6 across 5 years, with a median of $254000.0 in 2023.
- Annual changes were most pronounced in 2023 — Operating Leases plunged 91.67% — and 2024, when it jumped 2400.0%.
- Climb Bio's Operating Leases stood at $180000.0 in 2022, then sank by 91.67% to $15000.0 in 2023, then jumped by 2400.0% to $375000.0 in 2024, then dropped by 24.0% to $285000.0 in 2025, then slipped by 24.21% to $216000.0 in 2026.
- The last three Operating Leases figures came in at $216000.0 (Q1 2026), $285000.0 (Q4 2025), and $352000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Climb Bio | 740.73 Mn | 740.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 417,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 223,000.00 |
| Dec 31, 2022 | 180,000.00 |
| Sep 30, 2022 | 219,000.00 |
| Jun 30, 2022 | 695,000.00 |
| Mar 31, 2022 | 381,000.00 |